Universal Health Services reported second-quarter 2026 net income of $358.4 million, or $5.98 per diluted share, up from $353.2 million, or $5.43 per diluted share, in the prior year period. Consolidated net revenues increased 8.3% to $4.638 billion. Results included a $100 million favorable impact from the Florida Medicaid managed care directed payment program, partially offset by a $28 million increase in liability reserves. The company revised its full-year 2026 adjusted EPS forecast downward to a range of $22.28 to $23.65 per share, citing the expiration of the Florida program benefits after September 2025. UHS operates as a major provider of hospital and behavioral health care services in the United States.

Universal Health Services, Inc. entered into a Twelfth Amendment to its existing Credit Agreement on July 20, 2026, adding a new incremental delayed draw tranche A term loan facility of up to $700 million. This facility is available for drawdown between July 20, 2026, and September 30, 2026, with a maturity date occurring 364 days after funding. The company intends to use the proceeds for general corporate purposes, including refinancing existing debt. The loan features margins based on the Consolidated Net Leverage Ratio, initially starting at 0.125% for ABR Loans and 1.125% for Term Benchmark and RFR Loans. Universal Health Services, Inc. is a healthcare services provider.